Name: UMIN ID:
Unique ID issued by UMIN | UMIN000001847 |
---|---|
Receipt number | R000002221 |
Scientific Title | Phase II clinical trial of personalized peptide vaccination for refractory cervical cancer patients |
Date of disclosure of the study information | 2009/04/05 |
Last modified on | 2019/10/30 13:01:30 |
No. | Disposal | Last modified on | Item of update | |
---|---|---|---|---|
1 | Insert | 2009/04/03 18:45:47 | ||
2 | Update | 2009/04/04 10:20:59 | Classification by specialty |
|
3 | Update | 2009/04/04 10:22:03 | Last name of lead principal investigator |
|
4 | Update | 2009/04/10 16:33:59 | Recruitment status |
|
5 | Update | 2011/09/26 11:30:07 | UMIN ID1 |
|
6 | Update | 2011/09/28 10:31:05 | Recruitment status |
|
7 | Update | 2011/11/04 13:44:04 | Name of person sending information Name of person sending information Organization Division name Division name Post marketing survey by drug manufacture etc., specified by Japanese law. |
|
8 | Update | 2014/07/07 15:47:17 | Email Institute Institute Organization Organization Category of Funding Organization Nationality of Funding Organization Nationality of Funding Organization |
|
9 | Update | 2014/12/08 16:04:26 | Interventions/Control_1 Key inclusion criteria Key inclusion criteria Key exclusion criteria |
|
10 | Update | 2014/12/10 12:49:43 | Key secondary outcomes |
|
11 | Update | 2019/01/07 10:44:41 | Recruitment status |
|
12 | Update | 2019/10/30 13:01:30 | Recruitment status Date of IRB |